Deep Track Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
14
- Investments
-
109
- Portfolio
-
35
- Exits
-
52
Deep Track Capital General Information
Company Description
Founded in 2020, Deep Track Capital is a venture capital firm based in Greenwich, Connecticut. The firm prefers to invest in the biotechnology and life sciences sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.deeptrackcapital.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 200 Greenwich Avenue
- 3rd Floor
- Greenwich, CT 06830
- United States
Deep Track Capital Investments (109)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Mentari Therapeutics | 06-Nov-2026 | PIPE | Drug Discovery | Generating Revenue | ||
| Mentari Therapeutics | 06-Nov-2026 | Drug Discovery | Generating Revenue | |||
| Prana Therapies | 26-Oct-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Estuary Biotherapeutics | 16-Oct-2026 | Drug Discovery | Pre-Clinical Trials | |||
| North Immunology | 17-Sep-2026 | Biotechnology | Generating Revenue | |||
| Superluminal Medicines | 03-Sep-2026 | Drug Discovery | Pre-Clinical Trials | |||
| Slate Medicines | 17-Aug-2026 | Biotechnology | Clinical Trials - Phase 1 | |||
| Obsidian Therapeutics | 03-Aug-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| LB Pharmaceuticals | 29-Jul-2026 | PIPE | Drug Discovery | Generating Revenue | ||
| Draig Therapeutics | 14-Jul-2026 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 2 |
Deep Track Capital Exits (52)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Pyxis Oncology | 01-Oct-2026 | Public Investment 2nd Offering | |
| Latigo Bio | 06-Aug-2026 | ||
| Attovia Therapeutics | 05-Aug-2026 | ||
| Obsidian Therapeutics | 03-Aug-2026 | ||
| Crescent Biopharma | 16-Jul-2026 | ||
| Abivax | 06-Jul-2026 | ||
| Cybin | 25-Jun-2026 | ||
| Jade Biosciences | 03-Jun-2026 | ||
| Tubulis | 21-May-2026 | Merger/Acquisition | |
| Avalo Therapeutics | 07-May-2026 | Public Investment 2nd Offering |
Deep Track Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Deep Track Capital Co-Investors (216)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| RA Capital Management | 20 |
|
|
||
| Janus Henderson Investors |
|
|
|||
| Frazier Healthcare Partners |
|
|
|||
| Surveyor Capital |
|
|
|||
| BVF Partners |
|
|
Deep Track Capital FAQs
-
What is Deep Track Capital?
Founded in 2020, Deep Track Capital is a venture capital firm based in Greenwich, Connecticut.
-
When was Deep Track Capital founded?
Deep Track Capital was founded in 2020.
-
Where is Deep Track Capital headquartered?
Deep Track Capital is headquartered in Greenwich, CT.
-
What is Deep Track Capital's total asset value?
Deep Track Capital has around in total assets under management.
-
How many investments has Deep Track Capital made?
Deep Track Capital has made 109 investments.
-
What has Deep Track Capital invested in?
Deep Track Capital has made numerous investments in companies like Mentari Therapeutics, Prana Therapies, and Estuary Biotherapeutics within the Drug Discovery industry.
-
What has Deep Track Capital invested in recently?
Deep Track Capital's latest investment was on 06-Nov-2026 in Mentari Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
